All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark
Authors:
- Torsten LauritzenTLTorsten Lauritzen
- Annelli SandbaekASAnnelli Sandbaek
- Anders Helles CarlsenACAnders Helles Carlsen
- Knut Borch-JohnsenKBKnut Borch-Johnsen
- 1 October 2012
- journal article
- research article
- Published by Elsevier in Primary Care Diabetes
- Vol. 6 (3) , 193-200
Abstract
No abstract availableKeywords
Funding Information
- Aarhus Universitets Forskningsfond
- Novo Nordisk
- Novo Nordisk Fonden
- Sundhed og Sygdom, Det Frie Forskningsråd
This publication has 19 references indexed in Scilit:
- Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trialThe Lancet, 2011
- General practitioners’ adherence to guidelines on management of dyslipidaemia: ADDITION-DenmarkScandinavian Journal of Primary Health Care, 2009
- Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costsScandinavian Journal of Public Health, 2008
- A New Zealand Linkage Study Examining the Associations Between A1C Concentration and MortalityDiabetes Care, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Preventive health screenings and health consultations in primary care increase life expectancy without increasing costsScandinavian Journal of Public Health, 2007
- The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population‐based screening studyDiabetic Medicine, 2005
- Relationship between HbA1c and mortality in a Japanese populationDiabetologia, 2005
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal, 2003
- The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screeningInternational Journal of Obesity, 2000